ID: ALA137585

Max Phase: Preclinical

Molecular Formula: C8H10ClN3O

Molecular Weight: 199.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccn(C/C=C/CCl)c(=O)n1

Standard InChI:  InChI=1S/C8H10ClN3O/c9-4-1-2-5-12-6-3-7(10)11-8(12)13/h1-3,6H,4-5H2,(H2,10,11,13)/b2-1+

Standard InChI Key:  NZLSHCSJFKMBAO-OWOJBTEDSA-N

Associated Targets(Human)

PO3 (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 199.64Molecular Weight (Monoisotopic): 199.0512AlogP: 0.62#Rotatable Bonds: 3
Polar Surface Area: 60.91Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 0.18CX LogD: 0.18
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.57Np Likeness Score: -0.24

References

1. Phadtare S, Kessel D, Corbett TH, Renis HE, Court BA, Zimlicka J..  (1991)  Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.,  34  (1): [PMID:1992143] [10.1021/jm00105a064]

Source